Jerel A Banks

Biography

erel has been a director since October 25, 2016.  Dr. Banks is the Chief Investment Officer of Nant Capital, LLC.  Prior to joining Nant Capital, LLC, Dr. Banks served as vice president, portfolio manager and research analyst for the Franklin Biotechnology Discovery Fund at Franklin Templeton Investments from 2012 to 2015.  During his time as portfolio manager and research analyst the assets under management for the Franklin Biotechnology Discovery Fund reached $5 Billion (USD). Prior to his tenure at Franklin Templeton Investments, he worked as a biotechnology equity research analyst at Sectoral Asset Management from 2011-2012.  Sectoral Asset Management, a healthcare-focused global investment management company, managed a family of investment portfolios with total assets under management of $3 Billion (USD).  From 2008-2011, Jerel worked as a biotechnology equity research analyst at Apothecary Capital, the healthcare investment management team for the family investment office of the Bass Family of Fort Worth, Texas.  Jerel began his career in investment management as a healthcare equity research associate at Capital Research Company, and he was a member of the equity research team from 2006-2008.  Capital Research Company is the investment management company for the American Funds family of Mutual funds, and the assets under management exceed $1 Trillion (USD).  Dr. Banks earned an M.D. from the Brown University School of Medicine and a Ph.D. in Organic Chemistry from Brown University, and he holds an A.B. in Chemistry from Princeton University.

Research Interest

Molecular and Cell Biology